The total solar eclipse – the first visible from the continental U.S. since 1979 – will traverse the entire country in a band about 70 miles wide, beginning on the Oregon coast and ending 90 minutes later off the coast of South Carolina.
UC Berkeley is hosting a two-day conference Aug. 16-17 that will bring together farmers, doctors, patients, environmentalists, consumers, nonprofits, community leaders and scientists to discuss potential applications of CRISPR technology, ranging from human and animal health to agriculture and conservation.
The University of California yesterday filed its opening brief with the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., in support of its appeal of the U.S. Patent Trial and Appeal Board’s (PTAB) decision in the CRISPR-Cas9 interference.
Marian Cleeves Diamond, one of the founders of modern neuroscience who was the first to show that the brain can change with experience and improve with enrichment, and who discovered evidence of this in the brain of Albert Einstein, died July 25 at the age of 90 at her home in Oakland.
UC Berkeley researchers have discovered how Cas1-Cas2, the proteins responsible for the ability of the CRISPR immune system in bacteria to adapt to new viral infections, identify the site in the genome where they insert viral DNA so they can recognize it later and mount an attack.
With one eye on potential bioterrorism threats, the Defense Advanced Research Projects Agency today announced $65 million in funding to seven projects around the country – including one led by UC Berkeley – to improve the safety and accuracy of gene editing.
Chicken skin may provide tips on how to grow artificial skin for grafts that looks like normal human skin, complete with hair follicles and sweat pores. Just the right tension on growing skin could set up these organized structures without the need to add chemicals to trigger them.
The Defense Advanced Research Projects Agency has awarded UC Berkeley $21.6 million over four years to create a window into the brain through which researchers — and eventually physicians — can monitor and activate thousands to millions of individual neurons using light.
Research now shows that the countermeasure viruses came up with — inhibitory proteins referred to as anti-CRISPRs — can be used to improve CRISPR-Cas9 as a gene-therapy tool, decreasing off-target gene editing that could cause unwanted side effects.